dehydroepiandrosterone sulfate has been researched along with Genital Neoplasms, Female in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atherton, PJ; Barton, DL; Birrell, SN; Dockter, T; Griffin, P; Lafky, JM; Loprinzi, CL; Mattar, B; Shuster, LT; Sood, R; Terstriep, SA; Thielen, J | 1 |
| Creasman, WT; Hughes, CL; Wall, LL | 1 |
1 trial(s) available for dehydroepiandrosterone sulfate and Genital Neoplasms, Female
| Article | Year |
|---|---|
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Topics: Administration, Intravaginal; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Genital Neoplasms, Female; Gonadal Steroid Hormones; Humans; Middle Aged; Osteogenesis; Postmenopause; Tamoxifen; Testosterone; Vagina | 2018 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Genital Neoplasms, Female
| Article | Year |
|---|---|
Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Genital Neoplasms, Female; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged; Ovariectomy; Ovary; Testosterone | 1991 |